MRI-guided Neurosurgical Ablation Market: Impact of AI and Machine Learning
The global MRI-guided neurosurgical ablation market is witnessing substantial growth, driven by advancements in medical imaging technology and an increasing demand for minimally invasive neurosurgical procedures.
The innovative approach leverages real-time MRI guidance to accurately target and treat various neurological conditions, including brain tumors, epilepsy, and movement disorders. With its ability to enhance precision, reduce patient recovery time, and minimize surgical risks, MRI-guided neurosurgical ablation is becoming a preferred option among healthcare providers and patients worldwide.
The MRI-guided Neurosurgical Ablation Market size was valued at USD 412.08 million in 2023 and is expected to reach USD 654.69 million by 2032, growing at a CAGR of 5.28% over the forecast period of 2024-2032.
Future Scope
The future of the MRI-guided neurosurgical ablation market is promising, fueled by continued technological advancements and a growing prevalence of neurological disorders. The integration of artificial intelligence (AI) and machine learning (ML) in imaging and surgical systems is expected to revolutionize this field, enabling even greater accuracy and personalized treatment plans. Expanding applications beyond traditional neurosurgery, such as oncology and pediatric care, will further broaden the market’s scope. Additionally, increasing investments in healthcare infrastructure, particularly in emerging markets, are anticipated to drive growth over the next decade.
Market Segmentation
The MRI-guided neurosurgical ablation market can be segmented based on the following:
-
By Product Type
-
MRI Systems
-
Ablation Devices
-
Accessories
-
-
By Application
-
Brain Tumors
-
Epilepsy
-
Parkinson’s Disease
-
Chronic Pain Management
-
Other Neurological Disorders
-
-
By End-User
-
Hospitals
-
Ambulatory Surgical Centers
-
Specialty Clinics
-
-
By Geography
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
-
Regional Analysis
-
North America holds the largest market share due to the presence of advanced healthcare infrastructure, high adoption of innovative technologies, and a significant number of neurological disorder cases.
-
Europe follows closely, driven by increasing government investments in healthcare and strong R&D initiatives.
-
Asia-Pacific is expected to witness the fastest growth, supported by a rising geriatric population, growing awareness of neurosurgical treatments, and expanding healthcare facilities in countries like China and India.
-
Latin America and Middle East & Africa are emerging markets, showing potential due to improving healthcare access and increasing focus on medical tourism.
Key Market Players
- Medtronic (Visualase MRI-guided Laser Ablation System, O-arm Surgical Imaging System)
- Monteris Medical (NeuroBlate System, AtamA Stabilization System)
- Brainlab AG (Curve Image-Guided Surgery, Elements Laser Navigation Software)
- Insightec (Exablate Neuro, Exablate 4000 Series)
- Boston Scientific Corporation (Vercise Deep Brain Stimulation Systems, iLab Ultrasound Imaging System)
- Elekta AB (Leksell Gamma Knife Icon, Elekta Neuromag)
- Zimmer Biomet (ROSA ONE Brain, ROSA Planning Software)
- Stryker Corporation (Stryker NAV3i Image-Guided System, Airo TruCT Mobile Imaging System)
- Philips Healthcare (Ingenia Ambition 1.5T MRI, SmartPath to dStream MRI Upgrades)
- Siemens Healthineers (MAGNETOM Vida 3T MRI, syngo.via Neurosuite)
- GE HealthCare (SIGNA Architect MRI System, Omni Legend PET/CT System)
- Synaptive Medical (Modus V Digital Microscope, BrightMatter Guide)
- Varian Medical Systems (Edge Radiosurgery System, TrueBeam Radiotherapy System)
- MedActa International (MySolutions Personal Alignment Technology, GMK Sphere for Neurological Applications)
- KARL STORZ GmbH & Co. KG (Image1 S 4K Rubina System, NAV1 ENT Surgical Navigation)
- Hitachi Medical Systems (Echelon Oval 1.5T MRI, Oasis High-Field Open MRI)
- Inomed Medizintechnik GmbH (C2 Nerve Monitor, NeuroExplorer Navigation System)
- Hyperfine (Swoop Portable MRI System, Neurovascular Imaging Software)
- ClearPoint Neuro, Inc. (ClearPoint Neuro Navigation System, SmartFrame Stereotactic Frame)
- Integra LifeSciences Corporation (Camino ICP Monitor, DuraGen Dural Graft Matrix)
Get Scope Sample@ https://www.snsinsider.com/sample-request/4982
Key Points
-
Real-time MRI guidance ensures precise targeting, reducing risks and improving patient outcomes.
-
Growing prevalence of neurological disorders is a major driver for market growth.
-
Technological advancements, including AI and ML, are enhancing the effectiveness of neurosurgical ablation procedures.
-
The market is segmented into product type, application, end-user, and geography.
-
North America dominates the market, while Asia-Pacific is expected to grow at the fastest rate.
Conclusion
The MRI-guided neurosurgical ablation market is set to experience robust growth in the coming years, driven by advancements in technology, increasing demand for minimally invasive procedures, and rising awareness of neurological conditions. As the healthcare industry continues to evolve, this market is poised to play a critical role in improving patient care and surgical outcomes globally. Stakeholders, including manufacturers, healthcare providers, and investors, have a significant opportunity to capitalize on this rapidly growing field.
Contact Us:
Akash Anand – Head of Business Development & Strategy
Phone: +1-415-230-0044 (US)
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian